Trimethoxysilylpropanethiol

We are Trimethoxysilylpropanethiol CAS:4420-74-0 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:Trimethoxysilylpropanethiol
CAS.NO:4420-74-0
Synonyms:3-(Trimethoxysilyl)propanethiol;(3-Mercaptopropyl)triMethoxysilane; (3-Mercaptopropyl)-Trimethoxysilane;
Molecular Formula:C6H16O3SSi
Molecular Weight:196.34000
 
Physical and Chemical Properties:
Density:1.057;
Boiling point:213-215oC;
Flash point:88oC;
Index of Refraction:1.444;
 
Specification:
Appearance:White to light straw liquid clear liquid
Purity(GC):≥97.0%
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:It can be used as coupling agent to improve the adhesion of sulfur cured elastomers (polysulfide, polyurethane sealants)
to inorganic fillers(such as silica, clay, glass, mica and talc etc.), fiberglass and surfaces. Mineral-reinforced articles such as shoe soles, rubber rollers and wheels, white sidewalls, and wire and cable insulation also can be produced with lower silane loadings.
It can be used to improve properties of mineral filled elastomer, including modulus, tensile and tear strength, heat buildup, abrasion resistance, resilience, compression set and cure time.
It can be used as a pretreatment on minerals or added at the time of compounding.
It can be used to improve low-rolling resistance in silica-reinforced tire tread compounds.
 

Trimethoxysilylpropanethiol


Related News: Myelodysplastic syndromes (MDS) are conditions that can occur when the blood-forming cells in the bone marrow become dysfunctional and thus produce an inadequate number of circulating blood cells.isotiocianato de bencilo CAS:622-78-6 The API can be directly formulated, and the intermediate can only be used to synthesize the next product. Only through the intermediate can the API be manufactured.4-Butylresorcinol CAS:18979-61-8 The intravenous form of rigosertib has been studied in Phase 1, 2, and 3 clinical trials involving more than 1000 patients, and is currently being evaluated in a randomized Phase 3 international INSPIRE trial for patients with HR-MDS after failure of HMA therapy.5,8-dimetoxi-1,2,3,4-tetrahidronaftalen-2-ol CAS:69775-51-5 The intravenous form of rigosertib has been studied in Phase 1, 2, and 3 clinical trials involving more than 1000 patients, and is currently being evaluated in a randomized Phase 3 international INSPIRE trial for patients with HR-MDS after failure of HMA therapy.Under the sub-licensing agreement, Mankind will market the drug under its own trademark while Glenmark will manufacture and supply it to the drug firm.

Related Products
Product Name
Noopept View Details
4-Fluoro-2-methylbenzoic acid View Details
3-oxo-N-[4-(3-oxobutanoylamino)phenyl]butanamide View Details
2,4,6-Triisopropylbenzenesulfonyl chloride manufacturer 4-Methoxyphenylboronic acid manufacturer (2S,5S)-1-((S)-2-METHOXYCARBONYLAMINO)-3-METHYLBUTYRYL)-5-METHYLPYRROLIDINE-2-CARBOXYLIC ACIDpyrrolidine-2-carboxylic acid manufacturer 6-Methyl-2-(4-methylphenyl)imidazo[1,2-a]pyridine manufacturer 5-Formylsalicylic acid manufacturer